7 steps to help outreach leaders manage payer relationships


Outreach

Laboratory outreach programs sit at the intersection of clinical care and the healthcare payment system, as outreach leaders must secure appropriate reimbursement while advancing high-value testing. These seven steps can help support this work through proactive payer engagement, disciplined coverage management, and stewardship that extends into physician offices and outreach clients.

1.

Assign owners to monitor coverage changes and updates


Health plan medical policies and Medicare’s Local Coverage Determinations (LCD) and National Coverage Determinations (NCD) define what testing is covered, under what conditions, and with what documentation. These rules change frequently, vary by region and plan, and can lag clinical evidence. Treating them as a static reference leads to unexpected denials and strained provider relationships.

Outreach leaders should assign clear owners across compliance and revenue cycle and with medical directors to track updates and changes. Maintaining a matrix that maps high-volume and high-cost tests to coverage criteria, required diagnoses, frequency limits, and documentation standards can help everyone track and understand the changes.

2.

Engage payers proactively


When policies are ambiguous or outdated, engage payers through formal inquiries, medical policy review cycles, or collaborative discussions grounded in peer-reviewed evidence and real-world utilization data. This reduces surprises and positions the laboratory as a knowledgeable partner rather than a reactive bill submitter.

3.

Track data on denial root causes to better target interventions


Common reasons for denials include medical-necessity denials, incomplete documentation, coding mismatches, and prior authorization failures. Tracking denial root causes by test, payer, and ordering provider provides the data to target interventions on the highest-impact opportunities. This could include strengthening pre-analytical and coding processes by ensuring orders carry ICD-10 codes aligned with coverage criteria, running real-time eligibility and coverage checks where possible, and building an appeal workflow with clear escalation paths and communication templates grounded in policy and clinical evidence.

4.

Move beyond transactional billing to demonstrate value


Sometimes for advanced diagnostics, genetic testing, and molecular assays, it is important to move beyond transactional billing to demonstrate the full value of the tests. Outreach leaders should consider sharing aggregated, de-identified utilization and outcomes data that highlight clinical and economic value; negotiating for high-volume or unique services; and exploring value-based arrangements that reward appropriate utilization. Clear communication with clinicians about coverage limits and patient responsibility also reduces billing disputes and protects the patient experience.

5.

Encourage good test stewardship


Stewardship aims to ensure the right test for the right patient at the right time. In addition to supporting good patient care, this activity can help build trust with payers, who increasingly use utilization data in rate negotiations and network decisions. Because laboratories see orders across many practices, they are uniquely positioned to influence good testing stewardship.

This activity must extend into physician offices and outreach settings, where low-value tests may originate through habit, incomplete information, or defensive practice. In this environment, outreach programs can help clients improve their own quality metrics while reducing denial-related administrative burden by giving ordering providers concise, evidence-based guidance; embedding decision support through order sets, reflex algorithms, and EHR prompts; and sharing utilization reports with clients and clinicians. It is also important to recognize reductions alongside volume metrics so that stewardship is valued rather than seen as a revenue threat.

6.

Develop relationships with payers


Approach payers with data and solutions, not just appeals. This will shift the relationship from transactional to trusted partnership. Payers respond to evidence, making it beneficial to quantify the impact of your coverage, payment integrity, and stewardship work through reduced denials, improved appropriateness rates, and cost avoidance.

7.

Invest in tools and teams to focus on payer efforts


One of the first steps should be establishing the right tools and teams to support work related to payer relations. This should include establishing a cross-functional payer relations or coverage committee that meets regularly and investing in intelligence tools and denial analytics. With these things in place, outreach teams can best target provider education, utilization feedback, and other efforts where they will yield the most benefit, such as high-impact tests and high-volume practices.

Why this work matters

Treating coverage policy, payment integrity, and stewardship as interconnected priorities helps laboratories reduce denials and rework, protect margins, and reinforce their role in high-value care. The programs that succeed will move from reactive billing to proactive collaboration with payers, ordering clinicians, and the patients served by every test result.

View more outreach insights and education opportunities.

Jane Hermansen

Jane Hermansen is living her childhood dream of being a laboratory professional. With a passion for community-based medicine, she has worked with hundreds of hospitals across the US in outreach program development and growth. She currently directs the outreach consulting activities for Mayo Clinic Laboratories.